Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

Saved in:
Bibliographic Details
Main Authors: Mieke van Schaik, Aiko P.J. de Vries, Frederike J. Bemelman, Ton J. Rabelink, Leendert A. Trouw, Cees van Kooten, Yoe Kie Onno Teng
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S246802492401492X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690706312953856
author Mieke van Schaik
Aiko P.J. de Vries
Frederike J. Bemelman
Ton J. Rabelink
Leendert A. Trouw
Cees van Kooten
Yoe Kie Onno Teng
author_facet Mieke van Schaik
Aiko P.J. de Vries
Frederike J. Bemelman
Ton J. Rabelink
Leendert A. Trouw
Cees van Kooten
Yoe Kie Onno Teng
author_sort Mieke van Schaik
collection DOAJ
format Article
id doaj-art-393b9c6fb93c4e55a2099f30caa6412a
institution DOAJ
issn 2468-0249
language English
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-393b9c6fb93c4e55a2099f30caa6412a2025-08-20T03:21:14ZengElsevierKidney International Reports2468-02492024-06-01961919192210.1016/j.ekir.2024.02.1402Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 GlomerulopathyMieke van Schaik0Aiko P.J. de Vries1Frederike J. Bemelman2Ton J. Rabelink3Leendert A. Trouw4Cees van Kooten5Yoe Kie Onno Teng6Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Nephrology and Leiden Transplant Center, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Nephrology, Amsterdam University Medical Center, Amsterdam, The NetherlandsCenter of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Immunology, Leiden University Medical Center, Leiden, The NetherlandsCenter of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The NetherlandsCenter of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands; Correspondence: Yoe Kie Onno Teng, Leiden University Medical Center, Department of Nephrology, 9600, 2300RC Leiden, The Netherlands.http://www.sciencedirect.com/science/article/pii/S246802492401492X
spellingShingle Mieke van Schaik
Aiko P.J. de Vries
Frederike J. Bemelman
Ton J. Rabelink
Leendert A. Trouw
Cees van Kooten
Yoe Kie Onno Teng
Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
Kidney International Reports
title Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
title_full Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
title_fullStr Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
title_full_unstemmed Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
title_short Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
title_sort clinical remission and reduction of circulating nephritic factors by combining rituximab with belimumab in a case of complement factor 3 glomerulopathy
url http://www.sciencedirect.com/science/article/pii/S246802492401492X
work_keys_str_mv AT miekevanschaik clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT aikopjdevries clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT frederikejbemelman clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT tonjrabelink clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT leendertatrouw clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT ceesvankooten clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy
AT yoekieonnoteng clinicalremissionandreductionofcirculatingnephriticfactorsbycombiningrituximabwithbelimumabinacaseofcomplementfactor3glomerulopathy